69716-28-5

Basic information

• Product Name: 2-PyridinecarboxiMidoyl chloride, N-hydroxy-
• Synonyms: 2-PyridinecarboxiMidoyl chloride, N-hydroxy-;(Z)-N-HydroxypicoliniMidoyl chloride;N-Hydroxy-2-pyridinecarboximidoyl chloride;Pyridine-2-carbohydroximoyl chloride;N-Hydroxypicolinimidoyl chloride;(Z)-N-Hydroxypyridine-2-carbonimidoyl chloride;2-[chloro(nitroso)methylidene]-1H-pyridine
• CAS NO: 69716-28-5
• Molecular Formula: C₆H₅ClN₂O
• Molecular Weight: 156.5697
• Mol File: 69716-28-5.mol
• Article Data: 27

Chemical Properties

• Melting Point: 144℃ (benzene )
• Appearance: /
• Density: 1.34±0.1 g/cm3 (20 ºC 760 Torr)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 2-PyridinecarboxiMidoyl chloride, N-hydroxy-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-PyridinecarboxiMidoyl chloride, N-hydroxy-(69716-28-5)
• EPA Substance Registry System: 2-PyridinecarboxiMidoyl chloride, N-hydroxy-(69716-28-5)

Safety Data

• Hazardous Substances Data: 69716-28-5(Hazardous Substances Data)

Usage

Synthesis Reference(s)

Synthetic Communications, 18, p. 1427, 1988 DOI: 10.1080/00397918808078813

Upstream product

• 1772-01-6 (Z)-N'-hydroxy-pyridine-2-carboxamidine 
• 100-70-9 2-Cyanopyridine 
• 1193-96-0 (E)-pyridin-2-aldoxime 
• 1772-01-6 2-pyridylamidoxime 
• 1121-60-4 pyridine-2-carbaldehyde 
• 873-69-8 2-pyridinealdoxime 

Downstream Products

• 1353748-68-1 C₁₈H₁₇N₃O₃ 
• 1353748-63-6 C₁₉H₁₉N₃O₃ 
• 1236144-59-4 tert-butyl 1-(4-(5-(3-(pyridin-2-yl)-4-(trifluoromethyl)isoxazol-5-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate 
• 1236144-85-6 tert-butyl 1-(4-(5-(4-propyl-3-(pyridin-2-yl)isoxazol-5-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate 
• 1236144-62-9 5-(4-iodo-3-(pyridin-2-yl)isoxazol-5-yl)-3-p-tolyl-1,2,4-oxadiazole 
• 1236144-61-8 5-(4-bromo-3-(pyridin-2-yl)isoxazol-5-yl)-3-p-tolyl-1,2,4-oxadiazole 
• 1236144-60-7 5-(3-(pyridin-2-yl)isoxazol-5-yl)-3-p-tolyl-1,2,4-oxadiazole 
• 1236144-63-0 5-(3-(pyridin-2-yl)-4-(trifluoromethyl)isoxazol-5-yl)-3-p-tolyl-1,2,4-oxadiazole 
• 1236144-64-1 3-(4-(bromomethyl)phenyl)-5-(3-(pyridin-2-yl)-4-(trifluoromethyl)isoxazol-5-yl)-1,2,4-oxadiazole 
• 1236144-37-8 1-(4-(5-(3-(pyridin-2-yl)-4-(trifluoromethyl)isoxazol-5-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic acid 

Relevant articles and documents

CBP/CATENIN SIGNALING PATHWAY INHIBITORS AND USES THEREOF

Provided are compounds of formula (Ia), (Ib) and (IIa), and pharmaceutically acceptable salts thereof. Additionally provided are compositions and pharmaceutical compositions comprising the compounds, therapeutic methods using same for modulating (e.g., inhibiting) CREB binding protein (CBP)/β-catenin mediated signaling in treating a condition, disease or disorder (e.g., fibrosis, cancer, neurological conditions, metabolic disorders (e.g., diabetes, etc.), and skin conditions (dermatitis, psoriasis, scarring, alopecia, etc.) mediated by aberrant CBP/β -catenin signaling, and cosmetic methods for treating skin conditions (e.g., aging, etc.). Additionally provided are methods for enhancing vaccine efficacy using the compounds and compositions. Further provided are methods for efficiently synthesizing a clinical grade drug, comprising use, in a penultimate, or last reaction step under GMP conditions, of an intermediate 2-propynyl-compound to form a clinical grade isoxazole derivative (e.g., via 3+2 cycloaddition).

ADENOSINE ANALOGS FOR THE TREATMENT OF DISEASE

The disclosure provides adenosine analogs for the treatment of disease such as pain and inflammatory conditions.

Stereospecific 1,4-Metallate Shift Enables Stereoconvergent Synthesis of Ketoximes

Reported herein is a stereospecific 1,4-metallate rearrangement for single-geometry ketoxime synthesis from oxime chlorides and arylboronic acids. This strategy exhibits broad substrate scope with excellent stereoselectivity under mild reaction conditions. In comparison with the conventional approaches, each configuration of unsymmetric diaryl oximes, as well as the thermodynamically less stable Z isomer of aryl alkyl ketoximes can be selectively and exclusively obtained. The reactivities of unsymmetric diaryl oximes and the Z isomer of aryl alkyl oximes, a class of underexplored molecules, enables efficient access to the corresponding isoquinolines, isoquinoline N-oxides, and amides having a single configuration.